Leptospirosis is a zoonotic disease that infects humans through contact with urine of infected animals. The disease causes severe jaundice and potentially fatal complications affecting the kidneys and liver if not treated. Leptospirosis diagnostics tests help accurately diagnose the disease in infected patients.
The global Leptospirosis Market is estimated to be valued at US$ 496.8 Mn in 2023 and is expected to exhibit a CAGR of 4.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Increased government initiatives is one of the key trends driving the growth of the Leptospirosis market. Governments across the globe are undertaking initiatives to control the spread of the disease by implementing public health programs focussed on disease surveillance, antibiotic prophylaxis, and vaccination of animals. For instance, governments in Latin American and Caribbean countries implement annual mass vaccination campaigns for dogs. Government initiatives are aimed at increasing awareness regarding personal hygiene and spread of the disease from animals to humans. This is expected to fuel the adoption of Leptospirosis diagnostics testing kits, thereby accelerating revenue growth of the market over the forecast period.
The global leptospirosis market can be segmented based on strain type, diagnosis, treatment, and end-user. Based on strain type, the market is segmented into saprophyte and pathogenic. The pathogenic strain dominates the market as it is the causative agent of the leptospirosis disease in humans and animals. Based on diagnosis, the market is segmented into microscopic agglutination test, lateral flow, elisa and other. The microscopic agglutination test dominates as it is the gold standard serological test for the diagnosis of leptospirosis.
The Global Leptospirosis Market Demand is expected to witness high growth. It is projected to grow at a CAGR of 4.3% during the forecast period 2023 to 2030. The market size is estimated to reach US$ 496.8 Mn by 2024.
Regional analysis related content comprises Asia Pacific dominates the global leptospirosis market and is expected to continue its dominance during the forecast period. This is attributed to the increasing prevalence of the disease in regions like India and Southeast Asian countries due to unfavorable sanitation conditions.
Key players related content comprises Key players operating in the leptospirosis market are Cobham (U.K.), Harris Corporation (U.S.), AVIC (China), Raytheon (U.S.), Moog (U.S.), Ultra Electronics (U.K.), Circor Aerospace & Defense (U.S.), Systima Technologies (U.S.), Marotta Controls (U.S.), AEREA S.p.A (Italy).
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it